Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Series A Common Stock, $0.0001 par value per share
-
Shares outstanding
-
31,278,271
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
11,717,467
-
Shares change
-
+11,717,467
-
Total reported value, excl. options
-
$103,113,019
-
Value change
-
+$103,113,019
-
Number of buys
-
47
-
Price
-
$8.80
Institutional Holders of Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT) as of Q3 2023
As of 30 Sep 2023 Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT) had 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,717,467 shares of stock of the company.
Largest 10 holders included FMR LLC, HHLR ADVISORS, LTD., Artal Group S.A., BAKER BROS. ADVISORS LP, Rock Springs Capital Management LP, PFM Health Sciences, LP, VR Adviser, LLC, Altium Capital Management LP, RTW INVESTMENTS, LP, and PLATINUM INVESTMENT MANAGEMENT LTD.
This table shows 47 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.